A recent study concluded that although statins could theoretically cause fluid retention through AQP2 upregulation (since some hyponatremia case reports were identified regarding these drugs and ezetimibe), evidence suggested an inverse association between statins and hyponatremia, indicating a possible protective effect, though data were insufficient to support such a claim [153]. The gene discussed is AQP2; the disease is Hyponatremia.